Medical Marijuana Zone

Psilocybin, the psychedelic mushroom extract, has been fast-tracked by the FDA to treat depression, but doctors still can’t use it in their practice.

An excerpt from Weed Mom, the Canna-Curious Woman’s Guide to Healthier Relaxation, Happier Parenting, and Chilling TF Out, by Danielle Simone Brand.

Gut dysbiosis leads to decreased endocannabinoid signaling and reduced neurogenesis in the hippocampus. But dietary or probiotic interventions can mitigate stress-induced depressive syndromes.

Project CBD encourages CBD users to participate in a research study about CBD and cannabis use during the COVID-19 pandemic and its impact on health and well-being.

As the CBD industry keeps growing at an unprecedented rate in the United States and most Western countries, many entrepreneurs have started thinking about the business opportunities that it entails…. The post White Label CBD products: How Much Does It Cost to Start a CBD Business? appeared first on MedicalMarijuanaBlog.com.

At the beginning of December, Anvisa -Brazil’s national pharmaceutical regulator- gave the final green light to the country’s medical marijuana industry. While the decision could potentially benefit thousands of users… The post Brazil has Just Legalized Medical Marijuana – But There is a Catch appeared first on MedicalMarijuanaBlog.com.

Scientists have only recently begun to investigate and understand the critical role that the endocannabinoid system plays in alcohol addiction and various mood disorders.